Denis Chem Lab Receives 'Buy' Rating from MarketsMOJO, Shows Strong Financials and Bullish Trend

Jun 11 2024 06:26 PM IST
share
Share Via
Denis Chem Lab, a microcap company in the plastic products industry, has received a 'Buy' rating from MarketsMojo on June 11, 2024. The company has shown strong financial performance in the first half of 2024, with a low Debt to EBITDA ratio, high profits and ROCE, and efficient management of debtors. The stock is currently trading at an attractive valuation and has consistently outperformed the market. However, there are risks associated with its long-term growth potential.
Denis Chem Lab, a microcap company in the plastic products industry, has recently received a 'Buy' rating from MarketsMOJO on June 11, 2024. This upgrade is based on the company's strong ability to service debt, with a low Debt to EBITDA ratio of 0.48 times.

In addition, the company has shown positive results in the first half of 2024, with a 127.20% growth in profits and a highest ever ROCE of 19.26%. The company's DEBTORS TURNOVER RATIO is also at its highest at 5.30 times, indicating efficient management of its debtors.

Technically, the stock is in a bullish range and has shown improvement from a mildly bullish trend on June 11, 2024. Multiple factors such as MACD, Bollinger Band, KST, and DOW are all bullish for the stock.

With a ROE of 13.9, the stock is currently trading at a very attractive valuation with a price to book value of 3.1. It is also trading at a discount compared to its average historical valuations. Over the past year, the stock has generated a return of 130.30%, while its profits have risen by 41.7%. The PEG ratio of the company is 0.5, indicating a potential undervaluation.

Majority of the shareholders of Denis Chem Lab are non-institutional investors, which can be seen as a positive sign for the company. It has also consistently outperformed the BSE 500 index in the last 3 annual periods, further showcasing its strong performance.

However, there are some risks associated with investing in Denis Chem Lab. The company may face poor long-term growth as its net sales have only grown at an annual rate of 6.22% and operating profit at 12.38% over the last 5 years. Investors should carefully consider these risks before making any investment decisions.

Overall, Denis Chem Lab seems to be a promising investment opportunity with its strong financials, bullish technical trend, and attractive valuation. Investors should keep an eye on the company's long-term growth potential and make informed decisions based on their risk appetite.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
Why is GTL Infra. falling/rising?
9 seconds ago
share
Share Via
Why is Goodluck India falling/rising?
17 seconds ago
share
Share Via
Why is Grauer & Weil falling/rising?
19 seconds ago
share
Share Via
Why is DCM Financial falling/rising?
28 seconds ago
share
Share Via
Why is Aurionpro Sol. falling/rising?
28 seconds ago
share
Share Via
Why is Prism Medico falling/rising?
42 seconds ago
share
Share Via
Why is Vama Industries falling/rising?
54 seconds ago
share
Share Via